Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : MiUTR1R-00499
| Cat. No. | MiUTR1R-00499 |
| Description | miRNA 3′UTR target expression clone for Rat NM_001009539.1 |
| Gene Abbr | B4GALT3 |
| Gene Name | B4galt3 UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3 [ Rattus norvegicus ] |
| Species | Rat |
| Reporter | GLuc-SEAP |
| Promoter | Sv40 |
| Resistance | Amp |
| Selection Marker | Neomycin |
| Size | 10 μg purified plasmid |
| Vector | pEZX-MT05 |
| Vector Type | plasmid |
| Storage | -20 ℃ |
| Gene Name | B4galt3 UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3 [ Rattus norvegicus ] |
| Gene Symbol | B4GALT3 |
| Gene ID | 494342 |
| Uni Prot ID | Q6P768 |
| m RNA Refseq | NM_001009539.1 |
| Protein Refseq | NP_001009539.1 |
| Chromosome Location | 13q24 |
| Function | N-acetyllactosamine synthase activity; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; metal ion binding; |
| Pathway | Asparagine N-linked glycosylation, organism-specific biosystem; Disease, organism-specific biosystem; Glycosaminoglycan biosynthesis - keratan sulfate, organism-specific biosystem; Glycosaminoglycan biosynthesis - keratan sulfate, conserved biosystem; Glycosaminoglycan metabolism, organism-specific biosystem; Glycosphingolipid biosynthesis - lacto and neolacto series, organism-specific biosystem; Glycosphingolipid biosynthesis - lacto and neolacto series, conserved biosystem; Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer, organism-specific biosystem; Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer, conserved biosystem; Keratan sulfate biosynthesis, organism-specific biosystem; Keratan sulfate/keratin metabolism, organism-specific biosystem; MPS I - Hurler syndrome, organism-specific biosystem; MPS II - Hunter syndrome, organism-specific biosystem; MPS IIIA - Sanfilippo syndrome A, organism-specific biosystem; MPS IIIB - Sanfilippo syndrome B, organism-specific biosystem; MPS IIIC - Sanfilippo syndrome C, organism-specific biosystem; MPS IIID - Sanfilippo syndrome D, organism-specific biosystem; MPS IV - Morquio syndrome A, organism-specific biosystem; MPS IV - Morquio syndrome B, organism-specific biosystem; MPS IX - Natowicz syndrome, organism-specific biosystem; MPS VI - Maroteaux-Lamy syndrome, organism-specific biosystem; MPS VII - Sly syndrome, organism-specific biosystem; Metabolism, organism-specific biosystem; Metabolism of carbohydrates, organism-specific biosystem; Metabolism of proteins, organism-specific biosystem; Mucopolysaccharidoses, organism-specific biosystem; N-Glycan antennae elongation, organism-specific biosystem; N-Glycan biosynthesis, organism-specific biosystem; N-Glycan biosynthesis, conserved biosystem; N-glycan antennae elongation in the medial/trans-Golgi, organism-specific biosystem; N-glycan biosynthesis, complex type, organism-specific biosystem; N-glycan biosynthesis, complex type, conserved biosystem; Other types of O-glycan biosynthesis, organism-specific biosystem; Other types of O-glycan biosynthesis, conserved biosystem; Post-translational protein modification, organism-specific biosystem; Transport to the Golgi and subsequent modification, organism-specific biosystem; |
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.